![Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients]()
Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patientsVisvanathan, K.; Lang, T.; Ryan, K.; Wilson, R.; Skinner, N. A.; Thompson, A. J. V.; Ahn, S. H.; Weilert, F.; Abbott, W.; Gane, E.; Colledge, D.; Li, K.; Locarnini, S.; Mansell, A.; Revill, P. A. · Journal of Viral Hepatitis · 2016